In addition, immunohistochemical results showed that APG treatment not only alleviated TDP-43 in ALS mouse tissues, but also significantly counteracted the exacerbating effects of sh-ALDH1A2 on ALS mice (Fig. 8A). This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.